Genetics linked to rare blood clots from J&J and AstraZeneca Covid vaccines, researchers claim
- Researchers found that rare blood clots linked to Johnson & Johnson and AstraZeneca Covid-19 vaccines result from an autoimmune reaction some people are predisposed to.
- Adenovirus-Based vaccines, like J&J and AstraZeneca, contain a clot-triggering component for genetically susceptible individuals, impacting vaccine development.
- With 60 cases in over 18 million J&J vaccine recipients and 2-3 cases per 100,000 AstraZeneca shots under 60 in Australia, clot-related deaths occurred.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left4Leaning Right8Center2Last Updated1 month agoBias Distribution57% Right
Bias Distribution
- 57% of the sources lean Right
50% Right
L 19%
C 31%
R 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage